interview_age |
VALUE_RANGE, |
VALUE_RANGE: 0 :: 1260 |
VALUE_RANGE: 0::1440 |
04/04/2024 13:54 PM
|
ae |
ELEMENT_SIZE, |
ELEMENT_SIZE: 500 |
ELEMENT_SIZE: 4000 |
04/17/2023 14:18 PM
|
ae |
ELEMENT_SIZE, |
ELEMENT_SIZE: 250 |
ELEMENT_SIZE: 500 |
02/09/2023 14:59 PM
|
sex |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of subject at birth |
07/09/2021 10:38 AM
|
interview_date |
NOTES, |
NOTES: Required field |
NOTES: |
01/08/2021 10:21 AM
|
visit |
ELEMENT_SIZE, |
ELEMENT_SIZE: 50 |
ELEMENT_SIZE: 60 |
06/25/2020 10:25 AM
|
sex |
VALUE_RANGE, , NOTES, |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
VALUE_RANGE: M;F; O; NR
NOTES: M = Male; F = Female; O=Other; NR = Not reported |
02/21/2020 13:02 PM
|
gender |
PERMANENTLY ALIASED |
gender |
sex |
04/22/2019 00:00 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/22/2018 10:43 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Block Brief 2000: Sex of the subject |
DESCRIPTION: Sex of the subject |
08/20/2018 10:21 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Sex of the subject |
DESCRIPTION: Block Brief 2000: Sex of the subject |
08/14/2018 16:18 PM
|
visit |
NOTES, |
NOTES: Character description of each type of visit |
NOTES: |
07/18/2018 13:11 PM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYY |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging/biospecimen was completed. MM/DD/YYYY |
08/28/2017 15:10 PM
|
ae |
ELEMENT_SIZE |
ELEMENT_SIZE: 100 |
ELEMENT_SIZE: 250 |
02/10/2017 15:37 PM
|
gender |
VALUE_RANGE, NOTES |
VALUE_RANGE: M;F; T
NOTES: M = Male; F = Female; T= Transgender |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
05/25/2016 11:51 AM
|
gender |
DESCRIPTION |
DESCRIPTION: Gender |
DESCRIPTION: Sex of the subject |
05/25/2016 11:50 AM
|
gender |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
07/23/2015 11:32 AM
|
interview_age |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
07/23/2015 11:29 AM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYY |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYYY |
06/02/2015 17:40 PM
|
interview_date |
DESCRIPTION |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed |
DESCRIPTION: Date on which the interview/genetic test/sampling/imaging was completed. MM/DD/YYY |
06/02/2015 17:40 PM
|
interview_age |
VALUE_RANGE |
VALUE_RANGE: 0 :: 1200 |
VALUE_RANGE: 0 :: 1260 |
06/01/2015 14:16 PM
|
prf_term |
ELEMENT_SIZE |
ELEMENT_SIZE: 50 |
ELEMENT_SIZE: 100 |
06/01/2015 13:22 PM
|
phase_ct |
VALUE_RANGE |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase; Screening; Phase 1 |
05/28/2015 18:32 PM
|
phase_ct |
VALUE_RANGE |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B |
VALUE_RANGE: Pre-Rand; Phase 1/1A; Phase 2; Phase 3; Phase 4; Phase 1B; Open-Choice Phase |
05/28/2015 12:11 PM
|
interview_date |
REQUIRED |
REQUIRED: Recommended |
REQUIRED: Required |
03/26/2015 12:22 PM
|
ae |
NOTES |
NOTES: Character text of 18 AEs/side effects that were systematically queried at each visit |
NOTES: |
03/10/2015 14:30 PM
|
phase_ct |
DESCRIPTION |
DESCRIPTION: Current Phase. Phase patient was in at the time of the assessment Phase 4 refers to the follow-up phase.
|
DESCRIPTION: Current Phase. Phase patient was in at the time of the assessment Phase 4 refers to the follow-up phase. |
01/13/2015 17:38 PM
|
src_subject_id |
DESCRIPTION |
DESCRIPTION: The site or study's subject identification |
DESCRIPTION: Subject ID how it's defined in lab/project |
01/12/2015 18:22 PM
|
gender |
VALUE_RANGE, NOTES |
VALUE_RANGE: M;F
NOTES: M = Male; F = Female |
VALUE_RANGE: M;F; T
NOTES: M = Male; F = Female; T= Transgender |
12/01/2014 12:34 PM
|